Akira Kawamura to Diabetes Mellitus, Type 2
This is a "connection" page, showing publications Akira Kawamura has written about Diabetes Mellitus, Type 2.
Connection Strength
0.180
-
Takamiya Y, Imanaga C, Abe I, Kobayashi K, Ike A, Kawamura A, Urata H. Long-term renoprotective effect of luseogliflozin in type 2 diabetes patients: CHikushi Anti-diabetes mellitus Trial-Lusefi (CHAT-Lu). Drug Discov Ther. 2025 Jan 14; 18(6):336-342.
Score: 0.128
-
Ike A, Shirai K, Nishikawa H, Zhang B, Kawamura A, Iwata A, Mori K, Ogawa M, Miura S, Noda K, Saku K. [Series: clinical study from Japan and its reflections; impact of glycemic control on the clinical outcome in diabetic patients with percutaneous coronary intervention:--from the FU-registry--(UMIN registration no. 000005679)]. Nihon Naika Gakkai Zasshi. 2012 Feb 10; 101(2):504-11.
Score: 0.052